Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches.

immunoPET medullary thyroid carcinoma (MTC) pretargeted imaging radioimmunoconjugate theranostic (therapeutic and diagnostic)

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2019
Historique:
received: 19 02 2019
accepted: 17 05 2019
entrez: 20 6 2019
pubmed: 20 6 2019
medline: 20 6 2019
Statut: epublish

Résumé

Monoclonal antibody (mAb)-based therapies have experienced considerable growth in cancer management. When labeled with radionuclides, mAbs also represent promising probes for imaging or theranostic approaches. Initially, mAbs have been radiolabeled with single-photon emitters, such as

Identifiants

pubmed: 31214593
doi: 10.3389/fmed.2019.00124
pmc: PMC6558173
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

124

Références

J Nucl Med. 1998 Jul;39(7):1172-8
pubmed: 9669389
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):874-882
pubmed: 32820369
Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1377-83
pubmed: 23674207
J Clin Endocrinol Metab. 2007 Dec;92(12):4590-7
pubmed: 17878252
J Nucl Med. 2009 Jun;50(6):991-8
pubmed: 19443594
J Nucl Med. 2017 Oct;58(10):1553-1559
pubmed: 28687600
J Nucl Med. 2016 Oct;57(10):1505-1511
pubmed: 27230928
J Nucl Med. 2011 Dec;52(12):1855-63
pubmed: 22052128
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2166-2168
pubmed: 27539021
J Nucl Med. 2012 Dec;53(12):1863-71
pubmed: 23081996
J Nucl Med. 2009 Jan;50(1):2-5
pubmed: 19091888
Thyroid. 2015 Jun;25(6):567-610
pubmed: 25810047
Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1593-602
pubmed: 24643780
Mol Cancer Ther. 2010 Apr;9(4):1019-27
pubmed: 20354120
J Nucl Med. 1993 Aug;34(8):1267-73
pubmed: 8326383
J Nucl Med. 2006 Feb;47(2):247-55
pubmed: 16455630
Theranostics. 2016 Jan 01;6(1):93-103
pubmed: 26722376
J Nucl Med. 2006 Oct;47(10):1678-88
pubmed: 17015905
J Nucl Med. 2011 Aug;52(8):1171-2
pubmed: 21764784
J Nucl Med. 2013 Nov;54(11):1869-75
pubmed: 24029656
Angew Chem Int Ed Engl. 2010 Apr 26;49(19):3375-8
pubmed: 20391522
Front Med (Lausanne). 2015 Nov 27;2:84
pubmed: 26640780
Proc Natl Acad Sci U S A. 2006 May 2;103(18):6841-6
pubmed: 16636283
Br J Cancer. 2013 Aug 20;109(4):934-42
pubmed: 23860529
J Clin Endocrinol Metab. 2005 Apr;90(4):2029-34
pubmed: 15634717
Int J Mol Sci. 2016 Dec 28;18(1):
pubmed: 28036044
Oncotarget. 2018 Jun 08;9(44):27502-27513
pubmed: 29938001
Nat Med. 2018 Dec;24(12):1852-1858
pubmed: 30478423
J Nucl Med. 2012 Aug;53(8):1185-92
pubmed: 22743249
N Engl J Med. 1978 Jun 22;298(25):1384-6
pubmed: 349387
J Nucl Med. 2010 Jun;51(6):892-7
pubmed: 20484419
Thyroid. 2010 May;20(5):527-33
pubmed: 20450432

Auteurs

Caroline Bodet-Milin (C)

Nuclear Medicine, University Hospital, Nantes, France.
CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.

Clément Bailly (C)

Nuclear Medicine, University Hospital, Nantes, France.
CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.

Yann Touchefeu (Y)

CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.
Hepato-Gastro-enterology, University Hospital, Nantes, France.

Eric Frampas (E)

Nuclear Medicine, University Hospital, Nantes, France.
Radiology, University Hospital, Nantes, France.

Mickael Bourgeois (M)

Nuclear Medicine, University Hospital, Nantes, France.
CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.

Aurore Rauscher (A)

CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.
Nuclear Medicine, ICO Cancer Center, Saint-Herblain, France.

Franck Lacoeuille (F)

Nuclear Medicine, University Hospital, Angers, France.

Delphine Drui (D)

Endocrinology Department, University Hospital, Nantes, France.

Nicolas Arlicot (N)

Nuclear Medicine, University Hospital, Tours, France.

David M Goldenberg (DM)

IBC Pharmaceuticals, Inc., Morris Plains, NJ, United States.
Immunomedics, Inc., Morris Plains, NJ, United States.

Alain Faivre-Chauvet (A)

Nuclear Medicine, University Hospital, Nantes, France.
CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.

Jacques Barbet (J)

GIP Arronax, Saint-Herblain, France.

Caroline Rousseau (C)

CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.
Nuclear Medicine, ICO Cancer Center, Saint-Herblain, France.

Françoise Kraeber-Bodéré (F)

Nuclear Medicine, University Hospital, Nantes, France.
CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.
Nuclear Medicine, ICO Cancer Center, Saint-Herblain, France.

Classifications MeSH